Bearish flow noted in BridgeBio Pharma with 1,519 puts trading, or 2x expected. Most active are Feb-24 22.5 puts and Sep-23 25 puts, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 1.78, while ATM IV is up nearly 2 points on the day. Earnings are expected on November 2nd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBIO:
- BridgeBio Pharma put volume heavy and directionally bearish
- BridgeBio price target raised to $60 from $50 at Mizuho
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BridgeBio reports inducement grants under Nasdaq listing rule
- BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
